Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc0a0e12d541ce117e99c4fc292c92fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd8b4e13b98f10a8209e4b7b2e1692a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28b29f30052139b0f398e1ae91f97d35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51a5a0ede4cb859a8148725ac53af2d4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16222 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
filingDate |
2011-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52daf6d35256582305aa4dd925823146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_148969231d9807771aef3e65acb9d6bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bc8ca328a45bb01191a1b210a345f27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b2a3cc26ad9b53a1c231b5ab3be5309 |
publicationDate |
2012-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2536743-A1 |
titleOfInvention |
Human group p immunodeficiency virus and uses thereof |
abstract |
The present invention relates to Human Immunodeficiency Virus-1 (HIV-1) Group P of the strain designated 06CMU14788 and fragments thereof, primers which are derived from HIV-1 Group P, immunogenic regions thereof, immunoassays and nucleic acid based assays for the detection of Human Immunodeficiency Virus (HIV) that employ said HIV-1 Group P or fragments thereof and therapeutic compositions containing said HIV-1 Group P or fragments thereof. |
priorityDate |
2010-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |